Tonix Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $2,582 | $2,822 | $2,208 | $2,482 |
Gross Profit | 1,399 | 1,267 | -1,159 | 822 |
EBITDA | -21,058 | -15,554 | -17,392 | -20,379 |
EBIT | -21,554 | -16,064 | -18,597 | -21,589 |
Net Income | -22,108 | -14,213 | -78,776 | -14,939 |
Net Change In Cash | 2,582 | 2,822 | 2,208 | 2,482 |
Free Cash Flow | -14,633 | -18,810 | -9,919 | -17,683 |
Cash | 98,776 | 28,233 | 4,155 | 7,049 |
Basic Shares | 22 | 621 | 4,085 | 2,527 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,094 | $7,768 | $0 | $0 |
Gross Profit | 2,329 | 3,027 | -112,091 | -92,312 |
EBITDA | -71,729 | -114,089 | -110,838 | -92,262 |
EBIT | -75,150 | -118,380 | -112,091 | -92,312 |
Net Income | -130,036 | -116,658 | -115,004 | -92,212 |
Net Change In Cash | 10,094 | 7,768 | 0 | 0 |
Cost of Revenue | 101,623 | |||
Free Cash Flow | -61,045 | -109,898 | -146,200 | -110,864 |
Cash | 98,776 | 24,948 | 120,229 | 178,660 |
Basic Shares | 736 | 532 | 182 | 56 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$9.76 |
2024-09-30 | -$0.22 |
2024-06-30 | -$19.28 |
2024-03-31 | -$0.18 |
